Ketofol Versus Fenofol as Procedural Sedation for Carpal Tunnel Release

Last updated: February 8, 2021
Sponsor: Zagazig University
Overall Status: Active - Recruiting

Phase

1/2

Condition

Carpal Tunnel Syndrome

Treatment

N/A

Clinical Study ID

NCT04686448
6556
  • Ages 21-55
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

There are different methods of anesthesia for CTR surgery. Procedural sedation will allow rapid recovery and fewer complications than regional or general anesthesia (GA).

Attempts have been made in the past to use additives with propofol to reduce its dose. Ketofol (ketamine/propofol combination) was used for procedural sedation and analgesia. Ketamine and propofol administered in combination have offered effective sedation for spinal anesthesia and for gynecologic, ophthalmologic, and cardiovascular procedures in all age groups. The opposing hemodynamic and respiratory effects of each drug may enhance the utility of this drug combination, increasing both safety and efficacy and allowing reduction in the dose of propofol required to achieve sedation.

Propofol alone had a significantly greater number of apnea with desaturation (SpO2 < 90%) episodes. Further, it has been shown that during colonoscopies, propofol in combination with fentanyl provided similar patient satisfaction with shorter recovery times even at lower depths of sedation as compared to propofol. The addition of fentanyl to propofol has been shown to result in better operator feasibility with no difference in recovery time, cognitive impairment, or complications as compared to the use of propofol only for sedation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: 21-55 years old.
  • Sex: both sex (males or females).
  • Physical status: ASA I & II.
  • BMI: 25-30 kg/m2.
  • Type of operation: elective unilateral CTR under local anesthesia.
  • Written informed consent from the patient.
  • Cooperative patient.

Exclusion

Exclusion Criteria:

  • Patient refusal.
  • Altered mental status.
  • Patients with known history of allergy to study drugs.
  • Severe hepatic, renal, Cardiovascular and respiratory diseases.
  • Patients on regular sedative or pain killer medications.

Study Design

Total Participants: 56
Study Start date:
January 01, 2021
Estimated Completion Date:
May 01, 2021

Study Description

Sample size: assuming that the sedation using modified Ramasy sedation score was 6±0.01 in ketofol group versus 5.38±0.87 in fenofol group so the sample will be 56 patients, 28 patients in each group using OPENEPI at power 80 and CI 95 A computer-generated randomization table divided patients into 2 equal groups.

  • Group (K) (n=28): patients will receive IV ketofol (0.5 mg/kg ketamine and 1 mg/kg propofol) as bolus injection over 5 minutes in the same syringe then infusion of 0.05 mg/kg/min propofol increased or decreased rate of infusion according to achieve sedation response by modified Ramasy sedation score of ≤ 4.

  • Group (F) (n=28): patients will receive IV fenofol (1 µg/kg fentanyl and 1 mg/kg propofol) as bolus injection over 5 minutes in the same syringe then infusion of 0.05 mg/kg/min propofol increased or decreased rate of infusion according to achieve sedation response by modified Ramasy sedation score of ≤ 4.

The depth of sedation will be assessed by modified Ramsay sedation

Connect with a study center

  • Zagazig University

    Zagazig,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.